In this study, we found that the expression of TRIB3 increased with the advancement of clinical stage, pathological grade, primary tumor size, distant metastasis, and patient fustat, suggesting that TRIB3 promotes ccRCC progression and increases the risk of invasion and deterioration of ccRCC. Here, TRIB3 is linked to neoplasm.